SAN RAMON, Calif., Oct. 27, 2017 /PRNewswire/ -- BioVentrix, Inc. a pioneer of technologies and procedures for less invasive treatment of heart failure (HF), today announced that the Revivent TC™ TransCatheter Ventricular Enhancement System will be featured during the presentation of a...
For more information, please visit
https://www.prnewswire.com/news-releases[...]erapeutics-2017-300544948.html